RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/14962256http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

The influence of matrix-tumour interactions in Hodgkin's lymphoma is poorly characterised, although a large part of the tumour often consists of reactive tissue. The aim of the present study was to assess the clinicopathological role of two main inhibitors of matrix metalloproteinases, TIMP-1 and TIMP-2, in Hodgkin's lymphoma.

Materials and methods

The TIMP-1 and TIMP-2 protein expressions were studied from paraffin-embedded tumour sections of 68 patients with Hodgkin's lymphoma by using immunostaining with TIMP-1 and TIMP-2-specific antibodies. The results of the stainings were compared with the clinicopathological disease characteristics.

Results

A total of 33.3% of the tumour tissue sections expressed TIMP-1 and 46.8% expressed TIMP-2. The expression of the TIMP-1 protein was found to be strongly associated with the nodular sclerosis subtype (P = 0.015) and the existence of a bulky tumour (P = 0.004) in Hodgkin's lymphoma. The expression of the TIMP-2 protein, on the other hand, correlated with the occurrence of B symptoms (P = 0.032).

Conclusions

These results provide the first clinical evidence suggesting that TIMP-1 could promote growth of Hodgkin's lymphoma, and may be linked to connective tissue turnover in the nodular sclerosis subtype. However, TIMP-2 is shown to correlate with systemic symptoms."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.org/dc/terms/identifier"doi:10.1046/j.0902-4441.2004.00168.x"xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/author"Soini Y."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/author"Turpeenniemi-Hujanen T."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/author"Kuittinen O."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/author"Pennanen H."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/date"2004"xsd:gYear
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/name"Eur J Haematol"xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/pages"1-9"xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/title"Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma."xsd:string
http://purl.uniprot.org/citations/14962256http://purl.uniprot.org/core/volume"72"xsd:string
http://purl.uniprot.org/citations/14962256http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/14962256
http://purl.uniprot.org/citations/14962256http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/14962256
http://purl.uniprot.org/uniprot/#_A0A140VK57-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_B4DFW2-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_B3KQF4-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_B4DJK3-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_P01033-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_Q6FGX5-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_P16035-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/#_Q58P21-mappedCitation-14962256http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/B4DJK3http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/B4DFW2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/14962256
http://purl.uniprot.org/uniprot/Q58P21http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/14962256